PNNL's accomplishments in FY 2024 help address the remaining challenges the wind industry faces.

Early life exposure to polycyclic aromatic hydrocarbons (PAHs), found in smoke, has been linked to developmental problems. To study the impacts of these pollutants, PAH metabolism in infants and adults were compared.

PMedIC, the PNNL and OHSU joint research collaboration, contributes to student success and impact in biomedicine.

The nation is closer to its offshore wind energy goals than ever before, but better wind forecasting is still needed. To address this challenge, PNNL and collaborators are charting a new course with help from novel technology.

Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.

A research buoy managed by PNNL has been deployed in Hawai’ian waters, collecting oceanographic and meteorological measurements off the coast of O’ahu.

A multi-institutional team of wind energy experts led by PNNL assessed the scientific grand challenges for offshore wind and provided recommendations for closing gaps in models.

Multidisciplinary teams from research and industry are brought together using management systems developed by a team of software engineers at PNNL.

Silicone wristbands could be more convenient option for collecting exposure data.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

Exposure to polycyclic aromatic hydrocarbons found at Superfund Sites induces enzymes in dose- and time-dependent patterns in mice.